OTC: CHGCF - Chugai Pharmaceutical Co., Ltd.

Altı ay boyunca karlılık: -7.47%
Temettü getirisi: +2.96%
Sektör: Healthcare

Promosyon programı Chugai Pharmaceutical Co., Ltd.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.

daha fazla ayrıntı
It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета jpy
Див.доход ао 3.38
Дивиденд ао 1.13
Сайт https://www.chugai-pharm.co.jp
Цена ао 49.11
Günlük fiyat değişimi: 0% (44.23)
Haftalık fiyat değişimi: +1.24% (43.69)
Aylık fiyat değişimi: -14.28% (51.6)
3 ayda fiyat değişimi: +3.73% (42.64)
Altı ayda fiyat değişimi: -7.47% (47.8)
Yıllık fiyat değişimi: +13% (39.14)
Yılbaşından bu yana fiyat değişimi: +4.32% (42.4)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 7.8 1
P/BV 5.33 2
P/E 26.64 6
EV/EBITDA 18.38 6
Toplam: 5.38

Yeterlik

İsim Anlam Seviye
ROA, % 16.84 5
ROE, % 20.02 7
Toplam: 6.33

Temettüler

İsim Anlam Seviye
Div yield, % 2.96 7.4
DSI 0.9286 9.29
Toplam: 6.22

Görev

İsim Anlam Seviye
Debt/EBITDA 0.0301 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 61.96 8
karlılık Ebitda, % 113.37 10
karlılık EPS, % 106.17 10
Toplam: 9.6
Daha fazla ayrıntı

Daha fazla ayrıntı



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Osamu Okuda President, CEO & Chairman 1.44M 1963 (62 yıl)
Toshiya Sasai Executive of Investor Relations Group & Corporate Communications Department N/A
Mr. Shinji Hidaka Executive Vice President N/A
Mr. Junichi Ebihara Executive Vice President N/A
Dr. Yoshiaki Ohashi Senior VP & Full-time Audit Supervisory Board Member N/A 1960 (65 yıllar)
Mr. Tetsuya Yamaguchi Executive VP & Head of PHC Solution Unit N/A
Mr. Yoshiyuki Yano Executive Vice President N/A
Mr. Iwaaki Taniguchi Executive VP, Head of Finance Supervisory Division, CFO & Director 1967 (58 yıllar)
Mr. Masayoshi Higuchi VP and Head of Quality, Regulatory Compliance Unit, Business Strategy & Compliance Dept.
Junichi Takano Head of Marketing & Sales Division

Adres: Japan, Chuo, 2-1-1 Nihonbashi-Muromachi - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.chugai-pharm.co.jp